NEWSROOM

Coalition Innovation Santé: Chronolife, with the support of Servier, Launches in France a Non-Invasive Telemonitoring Solution for the Continuous Monitoring of Patients Suffering from Chronic Diseases

23 / 07 / 2020Press release

Servier and the Autonomous University of Barcelona collaborate to accelerate research into Parkinson’s disease

30 / 06 / 2020Press release

Coalition Innovation Santé: Cureety supported by Servier and Ipsen to accelerate the deployment of its solution ensuring the continuity of care for patients with cancer

15 / 06 / 2020Press release

Servier completes the acquisition of Symphogen

04 / 06 / 2020Press release

Allogene Therapeutics, with Collaborator Servier, Reports Positive Results from its Phase 1 ALPHA Study of ALLO-501 in Relapsed/Refractory Non-Hodgkin Lymphoma at the American Society of Clinical Oncology Annual Meeting

29 / 05 / 2020Press release

American Society of Clinical Oncology (ASCO) Abstract Reports Initial ALLO-501 ALPHA Phase 1 Data in Relapsed/Refractory Non-Hodgkin Lymphoma

14 / 05 / 2020Press release

Rgenta Therapeutics recipient of the Servier’s 2020 LabCentral Golden Ticket

05 / 05 / 2020Press release

Allogene Therapeutics, in Collaboration with Servier, to Present Initial Results from its Phase 1 ALPHA Study of ALLO-501 AlloCAR T Therapy in Relapsed/Refractory Non-Hodgkin Lymphoma at the American Society of Clinical Oncology

29 / 04 / 2020Press release

Kurma Partners announces the final closing of its Kurma Biofund III fund at €160 million

29 / 04 / 2020Press release

Servier signed a definitive agreement to acquire Symphogen, a leading antibody discovery company, to boost its antibody capabilities and leverage its R&D pipeline

03 / 04 / 2020Press release

Health Innovation Coalition Innovation in response to the Covid-19 health crisis

25 / 03 / 2020Press release

Pieris Pharmaceuticals Provides Update On Servier Collaboration

23 / 03 / 2020Press release